User profiles for David Henry
David HenryHonorary, Bond University, UNSW and UMelbourne, Australia; Emeritus, ICES and … Verified email at bond.edu.au Cited by 67539 |
[HTML][HTML] A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
Background: Most proton pump inhibitors inhibit the bioactivation of clopidogrel to its active
metabolite. The clinical significance of this drug interaction is unknown. Methods: We …
metabolite. The clinical significance of this drug interaction is unknown. Methods: We …
[HTML][HTML] Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group
Background A number of approaches have been used to grade levels of evidence and the
strength of recommendations. The use of many different approaches detracts from one of the …
strength of recommendations. The use of many different approaches detracts from one of the …
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
DH Henry, NV Dahl, M Auerbach… - The …, 2007 - academic.oup.com
Purpose. To evaluate the safety and efficacy of intravenous (IV) sodium ferric gluconate
complex (FG), oral ferrous sulfate, or no iron to increase hemoglobin (Hb) in anemic cancer …
complex (FG), oral ferrous sulfate, or no iron to increase hemoglobin (Hb) in anemic cancer …
A 3-year study of high-cost users of health care
Background: Characterizing high-cost users of health care resources is essential for the
development of appropriate interventions to improve the management of these patients. We …
development of appropriate interventions to improve the management of these patients. We …
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
The number of published systematic reviews of studies of healthcare interventions has
increased rapidly and these are used extensively for clinical and policy decisions. Systematic …
increased rapidly and these are used extensively for clinical and policy decisions. Systematic …
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Non-randomised studies of the effects of interventions are critical to many areas of healthcare
evaluation, but their results may be biased. It is therefore important to understand and …
evaluation, but their results may be biased. It is therefore important to understand and …
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews
…, E Kristjansson, J Grimshaw, DA Henry… - Journal of clinical …, 2009 - Elsevier
OBJECTIVE: Our purpose was to measure the agreement, reliability, construct validity, and
feasibility of a measurement tool to assess systematic reviews (AMSTAR). STUDY DESIGN …
feasibility of a measurement tool to assess systematic reviews (AMSTAR). STUDY DESIGN …
Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion
DA Henry, PA Carless, AJ Moxey… - Cochrane database …, 2011 - cochranelibrary.com
Background Concerns regarding the safety of transfused blood have led to the development
of a range of interventions to minimise blood loss during major surgery. Anti‐fibrinolytic …
of a range of interventions to minimise blood loss during major surgery. Anti‐fibrinolytic …
Selling sickness: the pharmaceutical industry and disease mongeringCommentary: Medicalisation of risk factors
R Moynihan, P CG, I Heath, D Henry - Bmj, 2002 - bmj.com
… Ray Moynihan, Iona Heath, and David Henry give examples of “disease mongering” and
suggest how to prevent … We thank David Newby for his help in conducting literature searches. …
suggest how to prevent … We thank David Newby for his help in conducting literature searches. …
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
…, JF Viallard, FJ Cuevas, RS Go, DH Henry… - The Lancet, 2008 - thelancet.com
Background Chronic immune thrombocytopenic purpura (ITP) is characterised by accelerated
platelet destruction and decreased platelet production. Short-term administration of the …
platelet destruction and decreased platelet production. Short-term administration of the …